dc.contributor.author | Chaparro Sánchez, María | |
dc.contributor.author | Barreiro-de Acosta, Manuel | |
dc.contributor.author | Benítez, José Manuel | |
dc.contributor.author | Cabriada, José Luis | |
dc.contributor.author | Casanova, María José | |
dc.contributor.author | Ceballos, Daniel | |
dc.contributor.author | Esteve, María | |
dc.contributor.author | Fernández, Hipólito | |
dc.contributor.author | Ginard, Daniel | |
dc.contributor.author | Gomollón, Fernando | |
dc.contributor.author | Lorente, Rufo | |
dc.contributor.author | Nos, Pilar | |
dc.contributor.author | Riestra, Sabino | |
dc.contributor.author | Rivero, Montserrat | |
dc.contributor.author | Robledo, Pilar | |
dc.contributor.author | Rodríguez, Cristina | |
dc.contributor.author | Sicilia, Beatriz | |
dc.contributor.author | Torrella, Emilio | |
dc.contributor.author | Garre, Ana | |
dc.contributor.author | García García-Esquinas, Esther | |
dc.contributor.author | Rodríguez Artalejo, Fernando | |
dc.contributor.author | Pérez Gisbert, Francisco Javier | |
dc.contributor.other | UAM. Departamento de Medicina | es_ES |
dc.contributor.other | UAM. Departamento de Medicina Preventiva y Salud Pública y Microbiología | es_ES |
dc.contributor.other | Instituto de Investigación del Hospital de La Princesa (IP) | es_ES |
dc.date.accessioned | 2019-10-30T16:51:42Z | |
dc.date.available | 2019-10-30T16:51:42Z | |
dc.date.issued | 2019-05-01 | |
dc.identifier.citation | Therapeutic Advances in Gastroenterology 12 (2019): 1-11 | en_US |
dc.identifier.issn | 1756-283X (print) | es_ES |
dc.identifier.issn | 1756-2848 (online) | es_ES |
dc.identifier.uri | http://hdl.handle.net/10486/689066 | |
dc.description.abstract | Background: Inflammatory bowel disease (IBD) is associated with a considerable burden to the patient and society. However, current data on IBD incidence and burden are limited because of the paucity of nationwide epidemiological studies, heterogeneous designs, and a low number of participating centers and sample size. The EpidemIBD study is a large-scale investigation to provide an accurate assessment of the incidence of IBD in Spain, as well as treatment patterns and outcomes. Methods: This multicenter, population-based incidence cohort study included patients aged >18 years with IBD (Crohn’s disease, ulcerative colitis, or unclassified IBD) diagnosed during 2017 in 108 hospitals in Spain, covering 50% of the Spanish population. Each participating patient will attend 10 clinic visits during 5 years of follow up. Demographic data, IBD characteristics and family history, complications, treatments, surgeries, and hospital admissions will be recorded. Results: The EpidemIBD study is the first large-scale nationwide study to investigate the incidence of IBD in Spain. Enrollment is now completed and 3627 patients are currently being followed up. Conclusions: The study has been designed to overcome many of the limitations of previous European studies into IBD incidence by prospectively recruiting a large number of patients from all regions of Spain. In addition to epidemiological information about the burden of IBD, the 5-year follow-up period will also provide information on treatment patterns, and the natural history and financial burden of IBD. | en_US |
dc.description.sponsorship | This research has been funded by grants from the Instituto de Salud Carlos III (FIS grant
PI16/01296 and PFI17/00143), a grant from GETECCU and a grant from MSD. | en_US |
dc.format.extent | 11 pag. | es_ES |
dc.format.mimetype | application/pdf | en |
dc.language.iso | eng | en |
dc.publisher | SAGE Publications (UK and US) | es_ES |
dc.relation.ispartof | Therapeutic Advances in Gastroenterology | en_US |
dc.rights | © The Author(s), 2019 | en_US |
dc.subject.other | Crohn’s disease | en_US |
dc.subject.other | Epidemiology | en_US |
dc.subject.other | Incidence | en_US |
dc.subject.other | Inflammatory bowel disease | en_US |
dc.subject.other | Ulcerative colitis | en_US |
dc.title | EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain | en_US |
dc.type | article | en |
dc.subject.eciencia | Medicina | es_ES |
dc.relation.publisherversion | https://doi.org/10.1177/1756284819847034 | es_ES |
dc.identifier.doi | 10.1177/1756284819847034 | es_ES |
dc.identifier.publicationfirstpage | 1 | es_ES |
dc.identifier.publicationissue | 12 | es_ES |
dc.identifier.publicationlastpage | 11 | es_ES |
dc.relation.projectID | Gobierno de España. PI16/01296 | es_ES |
dc.relation.projectID | Gobierno de España. PFI17/00143 | es_ES |
dc.type.version | info:eu-repo/semantics/submittedVersion | en |
dc.rights.cc | Reconocimiento – NoComercial | es_ES |
dc.rights.accessRights | openAccess | en |
dc.authorUAM | Chaparro Sánchez, María (274035) | |
dc.authorUAM | Rodríguez Artalejo, Fernando (259343) | |
dc.facultadUAM | Facultad de Medicina | |
dc.institutoUAM | Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa) | |